These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4311586

  • 1. Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis.
    Nakase Y, Takatsu K, Tateishi M, Sekiya K, Kasuga T.
    Jpn J Microbiol; 1969 Dec; 13(4):359-66. PubMed ID: 4311586
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of the body weight-decreasing toxicities in mice by the lymphocytosis-promoting factor and the heat-labile toxin of B. pertussis and endotoxin.
    Ishida S.
    Jpn J Med Sci Biol; 1968 Apr; 21(2):115-35. PubMed ID: 4299575
    [No Abstract] [Full Text] [Related]

  • 3. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y, Arai H.
    Tanpakushitsu Kakusan Koso; 1972 Apr; 17(2):139-49. PubMed ID: 4337077
    [No Abstract] [Full Text] [Related]

  • 4. Partial purification and some properties of the leukocytosis-promoting material from Bordetella pertussis.
    Sato Y, Arai H.
    Jpn J Med Sci Biol; 1970 Aug; 23(4):273-6. PubMed ID: 4099421
    [No Abstract] [Full Text] [Related]

  • 5. CHEMICAL STUDIES ON CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS. III. ISOLATION OF HIGHLY POTENT TOXIN FROM BORDETELLA PERTUSSIS.
    ONOUE K, KITAGAWA M, YAMAMURA Y.
    J Bacteriol; 1963 Oct; 86(4):648-55. PubMed ID: 14066457
    [Abstract] [Full Text] [Related]

  • 6. The partial purification and some biological activities of histamine sensitizing factor from Bordetella pertussis.
    Homma R, Kuratsuka K, Shimazaki Y, Funasaka I.
    Jpn J Med Sci Biol; 1970 Aug; 23(4):277-81. PubMed ID: 4321640
    [No Abstract] [Full Text] [Related]

  • 7. Attempts at analysis of toxicity of pertussis vaccine. II. Quantitative determination of the heat-labile toxin by skin reaction.
    Kurokawa M, Ishida S, Asakawa S.
    Jpn J Med Sci Biol; 1969 Oct; 22(5):293-307. PubMed ID: 4312799
    [No Abstract] [Full Text] [Related]

  • 8. Purified K-agglutinogen of Bordetella pertussis and its properties.
    Nakase Y, Kasuga T.
    Jpn J Microbiol; 1971 May; 15(3):247-56. PubMed ID: 4330023
    [No Abstract] [Full Text] [Related]

  • 9. [Gel filtration as a method of obtaining molecularly homogeneous bacterial toxins and anatoxins (a review of the literature)].
    Golshmid VK.
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):89-96. PubMed ID: 4616559
    [No Abstract] [Full Text] [Related]

  • 10. Antigens of Bordetella pertussis. II. Purification of heat-labile toxin.
    BANERJEA A, MUNOZ J.
    J Bacteriol; 1962 Aug; 84(2):269-74. PubMed ID: 13864610
    [Abstract] [Full Text] [Related]

  • 11. Purification and some properties of kappa toxin of Clostridium perfringens.
    Kameyama S, Akama K.
    Jpn J Med Sci Biol; 1971 Feb; 24(1):9-23. PubMed ID: 4325624
    [No Abstract] [Full Text] [Related]

  • 12. Disruption of Bordetella pertussis in the Ribi cell fractionator. 2. Effect of different suspending media.
    Hollinger E, Wardlaw AC.
    Can J Microbiol; 1971 Sep; 17(9):1195-202. PubMed ID: 4107161
    [No Abstract] [Full Text] [Related]

  • 13. Attempts at analysis of toxicity of pertussis vaccine. I. Body weight-decreasing toxicity in mice.
    Kurokawa M, Ishida S, Iwasa S, Asakawa S, Kuratsuka K.
    Jpn J Med Sci Biol; 1968 Apr; 21(2):137-53. PubMed ID: 4299576
    [No Abstract] [Full Text] [Related]

  • 14. Some characteristics of a heat-labile toxin from Pasteurella pseudotuberculosis.
    Brown JA, West WL, Banks WM, Marshall JD.
    J Infect Dis; 1969 Mar; 119(3):229-36. PubMed ID: 4976343
    [No Abstract] [Full Text] [Related]

  • 15. Purification of Clostridium perfringens type C theta toxin.
    Hauschild AH, Lecroisey A, Alouf JE.
    Can J Microbiol; 1973 Aug; 19(8):881-5. PubMed ID: 4356555
    [No Abstract] [Full Text] [Related]

  • 16. Attempts at isolation of lymphocytosis-producing factor from supernatant fluids of Bordetella pertussis cultures.
    Okuyama S, Aronson RB, Chanana AD, Cronkite EP, Rai KR, Schiffer LM.
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):723-7. PubMed ID: 4313155
    [No Abstract] [Full Text] [Related]

  • 17. [Electron microscopic study of B. pertussis during the isolation of a thermolabile toxin].
    Golubeva OS, Kushnarev VM.
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):22-5. PubMed ID: 4375918
    [No Abstract] [Full Text] [Related]

  • 18. Characterization and chemical modifications of toxins isolated from the venoms of the sea snake, Laticauda semifasciata, from Philippines.
    Tu AT, Hong B, Solie TN.
    Biochemistry; 1971 Apr 13; 10(8):1295-304. PubMed ID: 4996349
    [No Abstract] [Full Text] [Related]

  • 19. SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. I. IMMUNOLOGICAL AND OTHER BIOLOGICAL ACTIVITIES OF BORDETELLA PERTUSSIS ANTIGENS.
    MUNOZ JJ.
    Bacteriol Rev; 1963 Dec 13; 27(4):325-40. PubMed ID: 14097343
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of a heat-stable and heat-labile component of Bordetella pertussis in the depression of the murine hepatic mixed-function oxidase system.
    Williams JF, Lowitt S, Szentivanyi A.
    Biochem Pharmacol; 1980 Jun 01; 29(11):1483-90. PubMed ID: 6249317
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.